These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15996752)

  • 1. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder.
    Brambilla F; Mellado C; Alciati A; Pisu MG; Purdy RH; Zanone S; Perini G; Serra M; Biggio G
    Psychiatry Res; 2005 Jun; 135(3):185-90. PubMed ID: 15996752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder.
    Hardoy MC; Serra M; Carta MG; Contu P; Pisu MG; Biggio G
    J Clin Psychopharmacol; 2006 Aug; 26(4):379-84. PubMed ID: 16855455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of anxiolytic neurosteroids in men with normal anxiety scores: a correlation analysis.
    Brambilla F; Biggio G; Pisu MG; Purdy RH; Gerra G; Zaimovich A; Serra M
    Neuropsychobiology; 2004; 50(1):6-9. PubMed ID: 15179013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations.
    Zwanzger P; Eser D; Romeo E; di Michele F; Baghai TC; Pasini A; Padberg F; Rupprecht R
    Psychoneuroendocrinology; 2009 Nov; 34(10):1586-9. PubMed ID: 19501468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurosteroid secretion in panic disorder.
    Brambilla F; Biggio G; Pisu MG; Bellodi L; Perna G; Bogdanovich-Djukic V; Purdy RH; Serra M
    Psychiatry Res; 2003 May; 118(2):107-16. PubMed ID: 12798975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered profiles of serum neuroactive steroids in premenopausal women treated for alcohol addiction.
    Hill M; Popov P; Havlíková H; Kancheva L; Vrbíková J; Kancheva R; Pouzar V; Cerný I; Stárka L
    Steroids; 2005 Jul; 70(8):515-24. PubMed ID: 15894035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity.
    Paoletti AM; Romagnino S; Contu R; Orrù MM; Marotto MF; Zedda P; Lello S; Biggio G; Concas A; Melis GB
    Psychoneuroendocrinology; 2006 May; 31(4):485-92. PubMed ID: 16406349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroactive steroids in responders and nonresponders to sleep deprivation.
    Schüle C; Di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Ann N Y Acad Sci; 2004 Dec; 1032():216-23. PubMed ID: 15677414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A; Romeo E; di Michele F; Pasini A; Yassouridis A; Holsboer F; Rupprecht R
    Am J Psychiatry; 2002 Jan; 159(1):145-7. PubMed ID: 11772707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals.
    Brambilla F; Perini G; Serra M; Pisu MG; Zanone S; Toffanin T; Milleri S; Garcia CS; Biggio G
    Psychoneuroendocrinology; 2013 Oct; 38(10):2234-42. PubMed ID: 23702252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: A liquid chromatography-tandem mass spectrometry analysis.
    Deligiannidis KM; Kroll-Desrosiers AR; Tan Y; Dubuke ML; Shaffer SA
    Psychoneuroendocrinology; 2020 Nov; 121():104827. PubMed ID: 32828068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D; di Michele F; Zwanzger P; Pasini A; Baghai TC; Schüle C; Rupprecht R; Romeo E
    Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.
    Deligiannidis KM; Kroll-Desrosiers AR; Mo S; Nguyen HP; Svenson A; Jaitly N; Hall JE; Barton BA; Rothschild AJ; Shaffer SA
    Psychoneuroendocrinology; 2016 Aug; 70():98-107. PubMed ID: 27209438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy.
    Tuveri A; Paoletti AM; Orrù M; Melis GB; Marotto MF; Zedda P; Marrosu F; Sogliano C; Marra C; Biggio G; Concas A
    Epilepsia; 2008 Jul; 49(7):1221-9. PubMed ID: 18325018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Schwarz M; Rupprecht R; Romeo E
    Psychoneuroendocrinology; 2007 Jul; 32(6):669-80. PubMed ID: 17560730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not.
    Masdrakis VG; Papakostas YG; Vaidakis N; Papageorgiou C; Pehlivanidis A
    Depress Anxiety; 2008; 25(9):E72-9. PubMed ID: 17427182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
    Ströhle A; Romeo E; di Michele F; Pasini A; Hermann B; Gajewsky G; Holsboer F; Rupprecht R
    Arch Gen Psychiatry; 2003 Feb; 60(2):161-8. PubMed ID: 12578433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.